These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21149583)

  • 1. Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.
    Kamei A; Coutinho-Sledge YS; Goldberg JB; Priebe GP; Pier GB
    Infect Immun; 2011 Mar; 79(3):1289-99. PubMed ID: 21149583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
    Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
    J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From
    Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M
    Front Immunol; 2019; 10():2497. PubMed ID: 31708925
    [No Abstract]   [Full Text] [Related]  

  • 4. Collaboration between macrophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia.
    Kamei A; Wu W; Traficante DC; Koh AY; Van Rooijen N; Pier GB; Priebe GP
    J Infect Dis; 2013 Jan; 207(1):39-49. PubMed ID: 23100569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.
    Campodónico VL; Llosa NJ; Bentancor LV; Maira-Litran T; Pier GB
    Infect Immun; 2011 Aug; 79(8):3455-64. PubMed ID: 21628521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant.
    Priebe GP; Meluleni GJ; Coleman FT; Goldberg JB; Pier GB
    Infect Immun; 2003 Mar; 71(3):1453-61. PubMed ID: 12595463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous
    Liu C; Pan X; Xia B; Chen F; Jin Y; Bai F; Priebe G; Cheng Z; Jin S; Wu W
    Front Immunol; 2018; 9():1737. PubMed ID: 30093906
    [No Abstract]   [Full Text] [Related]  

  • 8. Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia.
    Baker SM; Pociask D; Clements JD; McLachlan JB; Morici LA
    Vaccine; 2019 Feb; 37(6):808-816. PubMed ID: 30638799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections.
    Meynet E; Laurin D; Lenormand JL; Camara B; Toussaint B; Le Gouëllec A
    Vaccine; 2018 Mar; 36(14):1893-1900. PubMed ID: 29506924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia.
    Wu W; Huang J; Duan B; Traficante DC; Hong H; Risech M; Lory S; Priebe GP
    Am J Respir Crit Care Med; 2012 Sep; 186(5):420-7. PubMed ID: 22723292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the Mechanistic Correlates of Protection Conferred by Whole-Cell Vaccination against Pseudomonas aeruginosa Acute Murine Pneumonia.
    Sen-Kilic E; Blackwood CB; Huckaby AB; Horspool AM; Weaver KL; Malkowski AC; Witt WT; Bevere JR; Damron FH; Barbier M
    Infect Immun; 2021 Jan; 89(2):. PubMed ID: 33199354
    [No Abstract]   [Full Text] [Related]  

  • 12. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
    Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
    Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
    Hatano K; Goldberg JB; Pier GB
    Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine.
    Priebe GP; Brinig MM; Hatano K; Grout M; Coleman FT; Pier GB; Goldberg JB
    Infect Immun; 2002 Mar; 70(3):1507-17. PubMed ID: 11854239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effects of nasal PcrV-CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia.
    Naito Y; Hamaoka S; Kinoshita M; Kainuma A; Shimizu M; Katoh H; Moriyama K; Ishii KJ; Sawa T
    Microbiol Immunol; 2018 Dec; 62(12):774-785. PubMed ID: 30378708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A live auxotrophic vaccine confers mucosal immunity and protection against lethal pneumonia caused by Pseudomonas aeruginosa.
    Cabral MP; Correia A; Vilanova M; Gärtner F; Moscoso M; García P; Vallejo JA; Pérez A; Francisco-Tomé M; Fuentes-Valverde V; Bou G
    PLoS Pathog; 2020 Feb; 16(2):e1008311. PubMed ID: 32040500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains.
    Hatano K; Pier GB
    Infect Immun; 1998 Aug; 66(8):3719-26. PubMed ID: 9673254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.
    Schaefers MM; Duan B; Mizrahi B; Lu R; Reznor G; Kohane DS; Priebe GP
    Vaccine; 2018 Nov; 36(46):6926-6932. PubMed ID: 30314911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.